Valéria Aparecida Bello
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Valéria Aparecida Bello has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Aline Vitali da Silva
Professora de Medicina na Pontifícia Universidade Católica do Paraná
23 shared publications - Regina Célia Poli-Frederico
North University of Paraná. Londrina. Paraná. Brazil
22 shared publications - Carlos Eduardo Coral de Oliveira
Pontifícia Universidade Católica do Paraná, Brazil
5 shared publications - Edna Maria Vissoci Reiche
Postgraduate Program of Clinical and Laboratory Pathophysiology, Health Sciences Center, Londrina State University, Londrina, Paraná, Brazil; Pontifical Catholic University of Paraná, Londrina Campus, School of Medicine, Londrina, Paraná, Brazil; Laboratory of Research in Applied Immunology, Health Sciences Center, Londrina State University, Londrina, Paraná, Brazil
5 shared publications - Amanda Brant Rocha
Pontifícia Universidade Católica do Paraná, Faculdade de Medicina, Departamento de Medicina, Londrina PR, Brazil
4 shared publications - Beatriz Bagatim Bossa
Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brasil
4 shared publications
Latest Publications
- Open Access
- 30 March 2025
- Published by Headache Medicine in Headache Medicine
- Vol. 16 (1) , 51-57
Hiperacusia e níveis plasmáticos de citocinas na enxaqueca
IntroduçãoA enxaqueca é uma dor crônica que representa um problema de saúde pública e compromete a qualidade de vida, com fator inflamatório envolvido em sua fisiopatologia.ObjetivoVerificar se há aumento de citocinas séricas em pacientes com enxaqueca associada à hiperacusia.MétodosA amostra foi composta por 80 participantes do grupo enxaqueca episódica e/ou crônica, com/sem aura, e 80 indivíduos saudáveis; com idade entre 18 e 60 anos, de ambos os sexos. Instrumentos utilizados: ID-migraine, Migraine Disability Assessment (MIDAS); Short-Form Headache Impact Test (HIT-6), State Trait Anxiety Inventory (STAI) Y1 Y2, Beck Inventory, Allodynia and Hyperacusis Questionnaire; dosagem de interleucina por citometria de fluxo.ResultadosA amostra foi homogênea quanto ao sexo, idade e raça (p>0,05). Houve associação entre hiperacusia e enxaqueca (p0,05) em pacientes com enxaqueca.ConclusãoFoi possível verificar que houve diferença significativa nos níveis plasmáticos de citocinas entre os grupos. O aumento dos marcadores inflamatórios indica a possibilidade de tratamento complementar, permitindo a intervenção de outros profissionais de equipes multi e interdisciplinares.
- 30 March 2025
- Published by Headache Medicine in Headache Medicine
- Vol. 16 (1) , 51-57
Open AccessHiperacusia e níveis plasmáticos de citocinas na enxaqueca
IntroduçãoA enxaqueca é uma dor crônica que representa um problema de saúde pública e compromete a qualidade de vida, com fator inflamatório envolvido em sua fisiopatologia.ObjetivoVerificar se há aumento de citocinas séricas em pacientes com enxaqueca associada à hiperacusia.MétodosA amostra foi composta por 80 participantes do grupo enxaqueca episódica e/ou crônica, com/sem aura, e 80 indivíduos saudáveis; com idade entre 18 e 60 anos, de ambos os sexos. Instrumentos utilizados: ID-migraine, Migraine Disability Assessment (MIDAS); Short-Form Headache Impact Test (HIT-6), State Trait Anxiety Inventory (STAI) Y1 Y2, Beck Inventory, Allodynia and Hyperacusis Questionnaire; dosagem de interleucina por citometria de fluxo.ResultadosA amostra foi homogênea quanto ao sexo, idade e raça (p>0,05). Houve associação entre hiperacusia e enxaqueca (p0,05) em pacientes com enxaqueca.ConclusãoFoi possível verificar que houve diferença significativa nos níveis plasmáticos de citocinas entre os grupos. O aumento dos marcadores inflamatórios indica a possibilidade de tratamento complementar, permitindo a intervenção de outros profissionais de equipes multi e interdisciplinares.
- Open Access
- 26 August 2024
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 82 (11) , 001-007
Relationship between food triggers and sensory hypersensitivity in patients with migraine
Background The recognition of food as the trigger of attacks occurs in approximately 25% of individuals with migraine. However, differentiating migraine food triggers and prodrome symptoms is still a challenge. Objective To understand the association of clinical characteristics of migraine with food triggers and to identify predictors of food triggers. Methods Patients with migraine diagnosed according to the criteria of the third edition of the International Classification of Headache Disorders (ICHD-3) were evaluated for the presence or absence of food triggers. Results In total, 502 patients with migraine were investigated, and they were divided into two groups: those with food triggers (58.4%) and those without food triggers (41.6%). The main food triggers were alcohol (44%), chocolate (42%), cheese (27.7%), excess carbohydrates (27.7%), coffee (21.8%), cold cuts (16%), and citrus fruits (11.9%). Aura and excessive use of analgesics were more frequent among patients with food triggers (p = 0.022). Photophobia and osmophobia were associated with the presence of a food trigger (p < 0.001). There was a greater impact of migraine in the presence of food triggers (p = 0.002). Through binary logistic regression, we identified clinical predictors of food triggers, such as photophobia and osmophobia. Conclusion The presence of a food trigger was significantly associated with photophobia and osmophobia. Osmophobia might be another mechanism by which patients perceive foods as triggers for their migraine attacks.
- 26 August 2024
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 82 (11) , 001-007
Open AccessRelationship between food triggers and sensory hypersensitivity in patients with migraine
Background The recognition of food as the trigger of attacks occurs in approximately 25% of individuals with migraine. However, differentiating migraine food triggers and prodrome symptoms is still a challenge. Objective To understand the association of clinical characteristics of migraine with food triggers and to identify predictors of food triggers. Methods Patients with migraine diagnosed according to the criteria of the third edition of the International Classification of Headache Disorders (ICHD-3) were evaluated for the presence or absence of food triggers. Results In total, 502 patients with migraine were investigated, and they were divided into two groups: those with food triggers (58.4%) and those without food triggers (41.6%). The main food triggers were alcohol (44%), chocolate (42%), cheese (27.7%), excess carbohydrates (27.7%), coffee (21.8%), cold cuts (16%), and citrus fruits (11.9%). Aura and excessive use of analgesics were more frequent among patients with food triggers (p = 0.022). Photophobia and osmophobia were associated with the presence of a food trigger (p < 0.001). There was a greater impact of migraine in the presence of food triggers (p = 0.002). Through binary logistic regression, we identified clinical predictors of food triggers, such as photophobia and osmophobia. Conclusion The presence of a food trigger was significantly associated with photophobia and osmophobia. Osmophobia might be another mechanism by which patients perceive foods as triggers for their migraine attacks.
- Open Access
- 4 July 2024
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 82 (10) , 001-007
Aura and osmophobia are associated with the IL1A -889C > T (rs1800587) variant in migraine
Background Migraine belongs to the group of primary headaches, affecting 14.4% of the global population. The pathophysiological mechanisms of migraine involve the interplay between hypothalamic activation, cortical spreading depression, trigeminal stimulation, and inflammatory components with neurogenic inflammation or neuroinflammation. Objective To assess the frequency of the IL1A -899C > T (rs1800587) genetic variant in patients with migraine and healthy controls, as well as its association with the clinical manifestations of migraine. Methods We conducted a case-control study involving 92 migraine patients and 88 healthy controls matched for age, sex, body mass index (BMI), and ethnicity. Demographic, anthropometric, and clinical data were obtained. The IL1A -889C > T (rs1800587) variant was identified using real-time polymerase chain reaction. Results The study comprised predominantly women and Caucasian individuals, with no significant differences in terms of age, sex, ethnicity, or BMI observed between the migraine and control groups. Within the migraine group, 57.6% had episodic migraines, and 45.7% experienced aura. The patients carrying the CT genotype showed stronger associations with the presence of aura (CT: 57.7%; TT: 27.5%; p = 0.027), and those carrying the CT and TT genotypes showed higher osmophobia rates when compared with the CC genotype (p = 0.003). The IL1A -889C > T genetic variant was not associated with migraine susceptibility, be it chronic or episodic, nor to other symptoms associated with migraine. Conclusion The IL1A -889C > T genetic variant was associated with aura and osmophobia in migraine patients.
- 4 July 2024
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 82 (10) , 001-007
Open AccessAura and osmophobia are associated with the IL1A -889C > T (rs1800587) variant in migraine
Background Migraine belongs to the group of primary headaches, affecting 14.4% of the global population. The pathophysiological mechanisms of migraine involve the interplay between hypothalamic activation, cortical spreading depression, trigeminal stimulation, and inflammatory components with neurogenic inflammation or neuroinflammation. Objective To assess the frequency of the IL1A -899C > T (rs1800587) genetic variant in patients with migraine and healthy controls, as well as its association with the clinical manifestations of migraine. Methods We conducted a case-control study involving 92 migraine patients and 88 healthy controls matched for age, sex, body mass index (BMI), and ethnicity. Demographic, anthropometric, and clinical data were obtained. The IL1A -889C > T (rs1800587) variant was identified using real-time polymerase chain reaction. Results The study comprised predominantly women and Caucasian individuals, with no significant differences in terms of age, sex, ethnicity, or BMI observed between the migraine and control groups. Within the migraine group, 57.6% had episodic migraines, and 45.7% experienced aura. The patients carrying the CT genotype showed stronger associations with the presence of aura (CT: 57.7%; TT: 27.5%; p = 0.027), and those carrying the CT and TT genotypes showed higher osmophobia rates when compared with the CC genotype (p = 0.003). The IL1A -889C > T genetic variant was not associated with migraine susceptibility, be it chronic or episodic, nor to other symptoms associated with migraine. Conclusion The IL1A -889C > T genetic variant was associated with aura and osmophobia in migraine patients.
- Open Access
- 14 June 2024
- Published by Headache Medicine in Headache Medicine
- Vol. 15 (2) , 54-63
O Papel do Sistema Imune na Fisiopatologia da Migrânea
A migrânea é uma doença caracterizada por episódios repetidos de cefaleia que são mediados pela ativação trigeminal e liberação do peptídeo CGRP. Adicionalmente existe uma complexa interação com o sistema imune através da inflamação neurogênica e neuroinflamação, com um desequilíbrio entre a resposta pró-inflamatória e a resposta regulatória. O sistema imune inato atua na migrânea principalmente por meio do aumento das citocinas pró-inflamatórias, com destaque para IL-1β cuja produção pode ocorrer no complexo córtex-meninge em decorrência da depressão cortical alastrante ou no gânglio trigeminal sensibilizado pelo CGRP. Algumas evidências sugerem também efeito do sistema imune adaptativo Th1 e principalmente Th2 que culmina com a ativação de mastócitos meníngeos. Por outro lado, células T regulatórias estão quantitativamente diminuídas na migrânea e acontecem oscilações dos níveis de IL-10, principal citocina anti-inflamatória. Existem evidências da atuação do sistema imune na migrânea, no entanto seu efeito ainda é pouco conhecido, com necessidade de investigação adicional.
- 14 June 2024
- Published by Headache Medicine in Headache Medicine
- Vol. 15 (2) , 54-63
Open AccessO Papel do Sistema Imune na Fisiopatologia da Migrânea
A migrânea é uma doença caracterizada por episódios repetidos de cefaleia que são mediados pela ativação trigeminal e liberação do peptídeo CGRP. Adicionalmente existe uma complexa interação com o sistema imune através da inflamação neurogênica e neuroinflamação, com um desequilíbrio entre a resposta pró-inflamatória e a resposta regulatória. O sistema imune inato atua na migrânea principalmente por meio do aumento das citocinas pró-inflamatórias, com destaque para IL-1β cuja produção pode ocorrer no complexo córtex-meninge em decorrência da depressão cortical alastrante ou no gânglio trigeminal sensibilizado pelo CGRP. Algumas evidências sugerem também efeito do sistema imune adaptativo Th1 e principalmente Th2 que culmina com a ativação de mastócitos meníngeos. Por outro lado, células T regulatórias estão quantitativamente diminuídas na migrânea e acontecem oscilações dos níveis de IL-10, principal citocina anti-inflamatória. Existem evidências da atuação do sistema imune na migrânea, no entanto seu efeito ainda é pouco conhecido, com necessidade de investigação adicional.
- Open Access
- 31 March 2023
- Published by Headache Medicine in Headache Medicine
- Vol. 14 (1) , 36-42
Headache changes in individuals with migraine post-Covid-19: general characteristics of the acute phase and worsening of the migraine pattern
IntroductionThe aim of this study was to investigate how infection with SARS-CoV-2 affected headache in individuals with migraine, and to identify characteristics associated with a worsening of the migraine post COVID-19.MethodsObservational study composed of 157 individuals with migraine and who had been infected with the SARS-CoV-2 virus. They were recruited from the database of the headache research group at the Pontifical Catholic University of Paraná. The participants responded online to questions about their anthropometric data, history of infection with SARS-CoV-2, presence and characteristics of the headache in the acute phase, perception of a worsening of the migraine after infection, use of analgesics and prophylactic migraine medication. Validated digital questionnaires were used: Migraine Disability Assessment (MIDAS), Beck Depression Inventory (BDI) and Allodynia Symptom Checklist (ASC-12). The results of these questionnaires were compared to values previously recorded in the database, this information having been obtained prior to the infection with COVID-19.ConclusionIndividuals who notice a worsening in migraine post-COVID-19 have a more severe migraine condition prior to infection, have more prominent headache during the acute phase and, subsequently, present with greater disability.
- 31 March 2023
- Published by Headache Medicine in Headache Medicine
- Vol. 14 (1) , 36-42
Open AccessHeadache changes in individuals with migraine post-Covid-19: general characteristics of the acute phase and worsening of the migraine pattern
IntroductionThe aim of this study was to investigate how infection with SARS-CoV-2 affected headache in individuals with migraine, and to identify characteristics associated with a worsening of the migraine post COVID-19.MethodsObservational study composed of 157 individuals with migraine and who had been infected with the SARS-CoV-2 virus. They were recruited from the database of the headache research group at the Pontifical Catholic University of Paraná. The participants responded online to questions about their anthropometric data, history of infection with SARS-CoV-2, presence and characteristics of the headache in the acute phase, perception of a worsening of the migraine after infection, use of analgesics and prophylactic migraine medication. Validated digital questionnaires were used: Migraine Disability Assessment (MIDAS), Beck Depression Inventory (BDI) and Allodynia Symptom Checklist (ASC-12). The results of these questionnaires were compared to values previously recorded in the database, this information having been obtained prior to the infection with COVID-19.ConclusionIndividuals who notice a worsening in migraine post-COVID-19 have a more severe migraine condition prior to infection, have more prominent headache during the acute phase and, subsequently, present with greater disability.
- 1 February 2023
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (5) , 2203-2208
Oral combined hormonal contraceptive associated with protection against allodynia in migraine in a cross-sectional study
Introduction For the most part, migraine afflicts young women who often need to use the hormonal contraceptive method. Objective To evaluate the effects of using exogenous estrogen, present in combined hormonal contraceptives (CHC) and progestin-only methods on the prevalence of allodynia in women with migraine. Methods Study comprising women diagnosed with migraine, with or without aura, who were not pregnant, breastfeeding, or menopausal. The study was conducted via the digital platform. Data were collected relating to demographics, contraceptive method, anthropometric information, smoking habits, and migraine-related symptoms. The participants then answered the following validated, self-administered questionnaires: Migraine Disability Assessment (MIDAS), Allodynia Symptom Checklist, Generalized Anxiety Disorder (GAD-7), and Beck’s Depression Inventory (BDI). In order to determine the variables associated with allodynia, two binary logistic regression models were used. Results Four hundred eighty-six women took part in the study. Of these, 205 used CHC, 89 used a progestin-only method, and 192 participants did not use any form of hormonal contraception. Allodynia was identified in 411 (84.6%) participants. Allodynia was linked to the presence of aura (OR = 2.76; CI 95% 1.55–4.91; p = 0.001), menstrually related migraine (OR = 2.14; CI 95% 1.28–3.57; p = 0.004), greater disability (MIDAS score 23 vs. 8; p < 0.001), depression (BDI score 14 vs. 10; p < 0.001), and anxiety (GAD-7 score 11 vs. 8; p < 0.001). In adjusted analysis, CHC was associated to protection against allodynia when jointly evaluated all CHC regimens (OR = 0.49 CI 95% 0.26–0.92; p = 0.028), as well as oral CHC individually (OR = 0.48 CI 95% 0.25–0.92; p = 0.027). Conclusion CHC reduced the chances of women with migraine getting allodynia.
- 1 February 2023
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (5) , 2203-2208
Oral combined hormonal contraceptive associated with protection against allodynia in migraine in a cross-sectional study
Introduction For the most part, migraine afflicts young women who often need to use the hormonal contraceptive method. Objective To evaluate the effects of using exogenous estrogen, present in combined hormonal contraceptives (CHC) and progestin-only methods on the prevalence of allodynia in women with migraine. Methods Study comprising women diagnosed with migraine, with or without aura, who were not pregnant, breastfeeding, or menopausal. The study was conducted via the digital platform. Data were collected relating to demographics, contraceptive method, anthropometric information, smoking habits, and migraine-related symptoms. The participants then answered the following validated, self-administered questionnaires: Migraine Disability Assessment (MIDAS), Allodynia Symptom Checklist, Generalized Anxiety Disorder (GAD-7), and Beck’s Depression Inventory (BDI). In order to determine the variables associated with allodynia, two binary logistic regression models were used. Results Four hundred eighty-six women took part in the study. Of these, 205 used CHC, 89 used a progestin-only method, and 192 participants did not use any form of hormonal contraception. Allodynia was identified in 411 (84.6%) participants. Allodynia was linked to the presence of aura (OR = 2.76; CI 95% 1.55–4.91; p = 0.001), menstrually related migraine (OR = 2.14; CI 95% 1.28–3.57; p = 0.004), greater disability (MIDAS score 23 vs. 8; p < 0.001), depression (BDI score 14 vs. 10; p < 0.001), and anxiety (GAD-7 score 11 vs. 8; p < 0.001). In adjusted analysis, CHC was associated to protection against allodynia when jointly evaluated all CHC regimens (OR = 0.49 CI 95% 0.26–0.92; p = 0.028), as well as oral CHC individually (OR = 0.48 CI 95% 0.25–0.92; p = 0.027). Conclusion CHC reduced the chances of women with migraine getting allodynia.
- Open Access
- 27 October 2022
- Published by Headache Medicine in Headache Medicine
- p. 16
Effects of migraine in cognition
Background Migraine is among the 3 most burdensome neurological disorders in the US in terms of absolute number of disability-adjusted life years (DALYs) from 1990 to 2017, behind just stroke and Alzheimer disease and other dementias. Migraine is characterized as a type of unilateral primary headache marked by a series of neurological and vascular alterations, which can occur episodically or chronically and course with intermittent attacks of intense or moderate headache. Moreover, cognitive dysfunctions are interim and disabling components of this disorder and may be related to the brain processes underlying the pathophysiology. Objective Examine the effects of migraine in the cognitive functions, such as language function, visuospatial function, attention, executive function and memory, of adults between 19 and 45 years old. Method This study consists in a narrative review of articles published in the last 5 years on MEDLINE database searched through PubMed. The articles were found using the following MESHs: Migraine and Cognition. Results We utilized 3 studies that approached cognitive impairment in migraine attacks and interictally. In a clinical trial, 144 pacients with chronic migraine (CM) and 44 age-matched patients with episodic migraine (EM) (a maximum of 4 headache days per month) were compared by cognitive assesments. In the Montreal Cognitive Assessment (MoCA), CM patients demonstrated the most striking impairment in memory/delayed recall (65.3%), attention (46.5%), abstraction (30.6%), and language (27.1%). (To see the complete abstract, please, check out the PDF).
- 27 October 2022
- Published by Headache Medicine in Headache Medicine
- p. 16
Open AccessEffects of migraine in cognition
Background Migraine is among the 3 most burdensome neurological disorders in the US in terms of absolute number of disability-adjusted life years (DALYs) from 1990 to 2017, behind just stroke and Alzheimer disease and other dementias. Migraine is characterized as a type of unilateral primary headache marked by a series of neurological and vascular alterations, which can occur episodically or chronically and course with intermittent attacks of intense or moderate headache. Moreover, cognitive dysfunctions are interim and disabling components of this disorder and may be related to the brain processes underlying the pathophysiology. Objective Examine the effects of migraine in the cognitive functions, such as language function, visuospatial function, attention, executive function and memory, of adults between 19 and 45 years old. Method This study consists in a narrative review of articles published in the last 5 years on MEDLINE database searched through PubMed. The articles were found using the following MESHs: Migraine and Cognition. Results We utilized 3 studies that approached cognitive impairment in migraine attacks and interictally. In a clinical trial, 144 pacients with chronic migraine (CM) and 44 age-matched patients with episodic migraine (EM) (a maximum of 4 headache days per month) were compared by cognitive assesments. In the Montreal Cognitive Assessment (MoCA), CM patients demonstrated the most striking impairment in memory/delayed recall (65.3%), attention (46.5%), abstraction (30.6%), and language (27.1%). (To see the complete abstract, please, check out the PDF).
- Open Access
- 27 October 2022
- Published by Headache Medicine in Headache Medicine
- p. 18
Influence of sleep and physical exercise in migraine patients
Introduction The prevalence of headache and sleep disorders is quite high in the general population. Both are chronic pathologies considered factors of daily disability which often coexists in migraine patients. A cause-and-effect relationship between migraine attacks and sleepless nights has not been confirmed yet, but it is already recognized that they have in common neuropeptides and functional anatomy in their pathogenesis. Because of this high prevalence, there are several studies on treatment options and prophylactic measures for migraine. The regular practice of physical exercises is identified as an important prevention factor for migraine attacks. However, daily intense physical activities are identified as triggers for these attacks. Objectives To investigate the correlation between sleep time and frequency of physical activity with headache days per month, migraine disability, allodynia, hyperacusis, anxiety and depression. Methods Cross-sectional study composed of 466 individuals of both sexes diagnosed with migraine. Patient data such as age, sex, race, body mass index (BMI), waist circumference, presence of hypertension and diabetes were analyzed. It was obtained information about the type of migraine (episodic or chronic; with or without aura), age of symptoms onset, duration of illness, use of prophylactic medication and excessive use of analgesics, as well as hours of sleep per night and frequency of practice of physical activity. Patients answered questionnaires to evaluate disability (Migraine Disability Assessment - MIDAS) and the impact of migraine (HIT-6), as well as questionnaires for anxiety (STAI Y1 and STAI Y2), depression (Beck Depression Scale), allodynia (ASC-12) and hyperacusis. Spearman's correlation test was performed and a statistical difference was considered when p ≤ 0.05. (To see the complete abstract, please, check out the PDF).
- 27 October 2022
- Published by Headache Medicine in Headache Medicine
- p. 18
Open AccessInfluence of sleep and physical exercise in migraine patients
Introduction The prevalence of headache and sleep disorders is quite high in the general population. Both are chronic pathologies considered factors of daily disability which often coexists in migraine patients. A cause-and-effect relationship between migraine attacks and sleepless nights has not been confirmed yet, but it is already recognized that they have in common neuropeptides and functional anatomy in their pathogenesis. Because of this high prevalence, there are several studies on treatment options and prophylactic measures for migraine. The regular practice of physical exercises is identified as an important prevention factor for migraine attacks. However, daily intense physical activities are identified as triggers for these attacks. Objectives To investigate the correlation between sleep time and frequency of physical activity with headache days per month, migraine disability, allodynia, hyperacusis, anxiety and depression. Methods Cross-sectional study composed of 466 individuals of both sexes diagnosed with migraine. Patient data such as age, sex, race, body mass index (BMI), waist circumference, presence of hypertension and diabetes were analyzed. It was obtained information about the type of migraine (episodic or chronic; with or without aura), age of symptoms onset, duration of illness, use of prophylactic medication and excessive use of analgesics, as well as hours of sleep per night and frequency of practice of physical activity. Patients answered questionnaires to evaluate disability (Migraine Disability Assessment - MIDAS) and the impact of migraine (HIT-6), as well as questionnaires for anxiety (STAI Y1 and STAI Y2), depression (Beck Depression Scale), allodynia (ASC-12) and hyperacusis. Spearman's correlation test was performed and a statistical difference was considered when p ≤ 0.05. (To see the complete abstract, please, check out the PDF).
- Open Access
- 27 October 2022
- Published by Headache Medicine in Headache Medicine
- p. 12
Genetic variants IL18 -105G>A and -137G>C associated with susceptibility to migraine
Introduction Few studies have been conducted into neurogenic inflammation and neuroinflammation in respect of migraine. However, evidence suggests that the immune system may exert an influence over trigeminal activation and cortical spreading depression in individuals suffering from migraine. The interleukin (IL)-18 is a pro-inflammatory cytokine and increased plasma levels have been confirmed in individuals with migraine. However, as yet, the genetic variants of IL-18 have not been investigated in the context of migraine. Objective To investigate the association between genetic variants IL18 -105G>A (rs360717) and IL18 -137G>C (rs187238) and susceptibility to migraine and its clinical characteristics. Subjects and Methods Case control study comprising 307 participants, of whom 152 had a diagnosis of migraine and 155 were healthy controls, paired by sex, age, ethnicity and BMI. The clinical and demographic data were evaluated. The patients with migraine were interviewed using a structured form containing information about the type of migraine (with or without aura, episodic or chronic), age at onset of the disease, frequency of attacks, accompanying symptoms that triggered headaches. The patients also answered validated questionnaires to evaluate incapacity (Migraine Disability Assessment - MIDAS) and impact (Headache Impact Test - HIT-6) for migraine, the presence of allodynia (ASC-12), as well as symptoms of anxiety (State Anxiety Inventory - STAI 1 and 2), depression (Beck Depression Inventory) and a hyperacusis scale. The genetic variants IL18 -105G>A (rs360717) and IL18 -137G>C (rs187238) were identified using polymerase chain reaction (PCR) and the fluorescence levels of PCR products were evaluated using a Step One thermocycler (Applied Biosystems). The analyses were conducted using the dominant, codominant, recessive and overdominant genetic models. (To see the complete abstract, please, check out the PDF).
- 27 October 2022
- Published by Headache Medicine in Headache Medicine
- p. 12
Open AccessGenetic variants IL18 -105G>A and -137G>C associated with susceptibility to migraine
Introduction Few studies have been conducted into neurogenic inflammation and neuroinflammation in respect of migraine. However, evidence suggests that the immune system may exert an influence over trigeminal activation and cortical spreading depression in individuals suffering from migraine. The interleukin (IL)-18 is a pro-inflammatory cytokine and increased plasma levels have been confirmed in individuals with migraine. However, as yet, the genetic variants of IL-18 have not been investigated in the context of migraine. Objective To investigate the association between genetic variants IL18 -105G>A (rs360717) and IL18 -137G>C (rs187238) and susceptibility to migraine and its clinical characteristics. Subjects and Methods Case control study comprising 307 participants, of whom 152 had a diagnosis of migraine and 155 were healthy controls, paired by sex, age, ethnicity and BMI. The clinical and demographic data were evaluated. The patients with migraine were interviewed using a structured form containing information about the type of migraine (with or without aura, episodic or chronic), age at onset of the disease, frequency of attacks, accompanying symptoms that triggered headaches. The patients also answered validated questionnaires to evaluate incapacity (Migraine Disability Assessment - MIDAS) and impact (Headache Impact Test - HIT-6) for migraine, the presence of allodynia (ASC-12), as well as symptoms of anxiety (State Anxiety Inventory - STAI 1 and 2), depression (Beck Depression Inventory) and a hyperacusis scale. The genetic variants IL18 -105G>A (rs360717) and IL18 -137G>C (rs187238) were identified using polymerase chain reaction (PCR) and the fluorescence levels of PCR products were evaluated using a Step One thermocycler (Applied Biosystems). The analyses were conducted using the dominant, codominant, recessive and overdominant genetic models. (To see the complete abstract, please, check out the PDF).
- Open Access
- 27 October 2022
- Published by Headache Medicine in Headache Medicine
- p. 13
Genetic variants IL1B +3954C>T and -511C>T associated with incapacity and allodynia in migraine
Introduction The main mechanisms in the physiopathology of migraine are cortical spreading depression and trigeminal activation with the release of CGRP. Neurogenic inflammation and neuroinflammation can exert an influence over both these mechanisms, but there are still a number of gaps in our understanding. Interleukin (IL)- 1β is a pro-inflammatory cytokine whose levels of plasma increase during the attack phase of migraine. Thus far, its genetic variants have not been well studied. Objective To investigate the association between the genetic variants IL1B +3954C>T (rs1143634) and -511C>T (rs16944) and susceptibility to migraine and its clinical characteristics. Subjects and Methods Case control study comprising 307 participants, of whom 152 had a diagnosis of migraine and 155 were healthy controls, paired by sex, age, ethnicity and BMI. The clinical and demographic data were evaluated. The patients with migraine were interviewed using a structured form containing information about the type of migraine (with or without aura, episodic or chronic), age at onset of the disease, frequency of attacks, accompanying symptoms that triggered headaches. The patients also answered validated questionnaires to evaluate incapacity (Migraine Disability Assessment - MIDAS) and impact (Headache Impact Test - HIT-6) for migraine, the presence of allodynia (ASC-12), as well as symptoms of anxiety (State Anxiety Inventory - STAI 1 and 2), depression (Beck Depression Inventory) and a hyperacusis scale. The genetic variants IL1B +3954C>T (rs1143634) and -511C>T (rs16944) were identified using polymerase chain reaction (PCR) and the fluorescence levels of PCR products were evaluated using a Step One thermocycler (Applied Biosystems). The analyses were conducted using the dominant, codominant, recessive and over- dominant genetic models. Categorical data were evaluated via the chi-squared test or Fisher’s exact test, and continuous data were evaluated using the Mann-Whitney test. (To see the complete abstract, please, check out the PDF).
- 27 October 2022
- Published by Headache Medicine in Headache Medicine
- p. 13
Open AccessGenetic variants IL1B +3954C>T and -511C>T associated with incapacity and allodynia in migraine
Introduction The main mechanisms in the physiopathology of migraine are cortical spreading depression and trigeminal activation with the release of CGRP. Neurogenic inflammation and neuroinflammation can exert an influence over both these mechanisms, but there are still a number of gaps in our understanding. Interleukin (IL)- 1β is a pro-inflammatory cytokine whose levels of plasma increase during the attack phase of migraine. Thus far, its genetic variants have not been well studied. Objective To investigate the association between the genetic variants IL1B +3954C>T (rs1143634) and -511C>T (rs16944) and susceptibility to migraine and its clinical characteristics. Subjects and Methods Case control study comprising 307 participants, of whom 152 had a diagnosis of migraine and 155 were healthy controls, paired by sex, age, ethnicity and BMI. The clinical and demographic data were evaluated. The patients with migraine were interviewed using a structured form containing information about the type of migraine (with or without aura, episodic or chronic), age at onset of the disease, frequency of attacks, accompanying symptoms that triggered headaches. The patients also answered validated questionnaires to evaluate incapacity (Migraine Disability Assessment - MIDAS) and impact (Headache Impact Test - HIT-6) for migraine, the presence of allodynia (ASC-12), as well as symptoms of anxiety (State Anxiety Inventory - STAI 1 and 2), depression (Beck Depression Inventory) and a hyperacusis scale. The genetic variants IL1B +3954C>T (rs1143634) and -511C>T (rs16944) were identified using polymerase chain reaction (PCR) and the fluorescence levels of PCR products were evaluated using a Step One thermocycler (Applied Biosystems). The analyses were conducted using the dominant, codominant, recessive and over- dominant genetic models. Categorical data were evaluated via the chi-squared test or Fisher’s exact test, and continuous data were evaluated using the Mann-Whitney test. (To see the complete abstract, please, check out the PDF).